Skip to main content
NKTR $36.32 -2.55%
NKTR logo
NKTR · Nektar Therapeutics
Track NKTR — free
$36.32 -0.95 (-2.55%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.28B
Shares
34.21M
Volume · Nov 16 216.39K Avg daily vol (3M) 1.1M
All webcasts

Earnings call · FY2024 Q2

Nektar Therapeutics (NKTR) Q2 2024 Earnings Call

Concluded Aug 8, 2024
Aug 8, 2024
Period
FY2024 Q2
Runtime
—
Sources
2 artifacts
Revenue $23.49M +14.6% YoY
Diluted EPS -$3.76
Gross margin · derived Q4 58.5% -7.4 pp YoY
Net income -$52.36M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Non Cash Royalty Revenue Related to Sale of Future Royalties$16.79M +6.1% YoY
Product$6.64M +42.6% YoY
License Collaboration and Other Revenue$59,000 +555.6% YoY
Full-screen source Call document